A strong deals market provides greater opportunity for growth, but also greater risk for errors in ethical behavior. Issues, after all, don’t develop from a lack of knowing right from wrong, but rather, in not having a clear understanding of who your clients are (vs. who they are not), what your clients prioritize as success, how attorney-client privilege is ultimately preserved, and where (unforeseen) difficulties may arise. In addition to addressing these core challenges, our panel will touch upon “headline” complexities such as “Weinstein clauses” and ethical considerations specific to cross-border deals.
Carol Morgan, Clinical Professor, Director, Business Law and Ethics Program, University of Georgia School of Law
Theodore I. Blum, Shareholder, Greenberg Traurig, LLP
Elizabeth Edelman, General Counsel; Compliance and Privacy Officer, RiverMend Health
Mark Kuehnert, Executive Director, Forensic & Integrity Services, Ernst & Young LLP
Jill Rothstein, Assistant General Counsel, Nelson Mullins Riley & Scarborough LLP